Affinity matters for IgE-blocking activity of allergen-specific antibodies.

Autor: Strobl MR; Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Demir H; Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Stadlmayr G; Department of Biotechnology, Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria., Stracke F; Department of Biotechnology, Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria., Hoelzl R; Department of Biotechnology, Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria., Bohle B; Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Wozniak-Knopp G; Department of Biotechnology, Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.

Publikováno v: Allergy [Allergy] 2023 Sep; Vol. 78 (9), pp. 2543-2546. Date of Electronic Publication: 2023 Apr 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved? : Results from the DA VINCI study.

Autor: Siostrzonek P; Department of Internal Medicine 2, Cardiology, Ordensklinikum Linz, Barmherzige Schwestern, Seilerstätte 4, 4010, Linz, Austria. peter.siostrzonek@ordensklinikum.at., Brath H; Diabetes & Metabolic Outpatient Clinic, Health Centre Favoriten, Vienna, Austria., Zweiker R; Cardiology Department, Medical University Graz, Graz, Austria., Drexel H; Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria., Hoelzl R; Amgen GmbH, Vienna, Austria., Hemetsberger M; hemetsberger medical services, Vienna, Austria., Ray KK; Imperial Centre for Cardiovascular Disease Prevention and Imperial Clinical Trials Unit, Imperial College London, London, UK.

Publikováno v: Wiener klinische Wochenschrift [Wien Klin Wochenschr] 2022 Apr; Vol. 134 (7-8), pp. 294-301. Date of Electronic Publication: 2021 Dec 06.

The impact of nitrogen on the defect aggregation in silicon

Autor: von Ammon, W. ^*, Hölzl, R., Virbulis, J., Dornberger, E., Schmolke, R., Gräf, D.

Publikováno v: In Journal of Crystal Growth 2001 226(1):19-30

Gettering efficiencies of polysilicon-, stacking fault- and He-implanted backsides for Cu and Ni

Autor: Hoelzl, R ^*, Range, K.-J, Fabry, L, Hage, J, Raineri, V

Publikováno v: In Materials Science & Engineering B 2000 73(1):95-98